Literature DB >> 3126148

Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.

J A Giménez1, H Sugiyama.   

Abstract

The toxin of Clostridium butyricum strains isolated from two infants with botulism is neutralized by antitoxin for type E botulinum toxin. This toxin and that of a C. botulinum type E strain were purified by the same protocol. Both toxins were Mr 145,000 proteins which, when activated with trypsin, were composed of an H subunit of Mr 105,000 and an L subunit of Mr 50,000. The activated specific toxicity of purified butyricum toxin based on an intravenous assay was 2 X 10(8) mouse 50% lethal doses (LD50s)/mg of protein, but that based on an intraperitoneal assay was 7 X 10(7) LD50s/mg, compared with 6 X 10(7) LD50s/mg for type E toxin as determined by both methods. Immunodiffusion tests with antitoxin raised with type E toxin indicated that the two toxins were serologically very similar except for a spur formed by type E toxin. The close similarities of the two toxins suggest that toxigenic C. butyricum could arise when a wild-type strain, which is normally nontoxigenic, acquires the toxin gene of a C. botulinum type E strain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126148      PMCID: PMC259392          DOI: 10.1128/iai.56.4.926-929.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Simplified purification method for Clostridium botulinum type E toxin.

Authors:  J A Giménez; H Sugiyama
Journal:  Appl Environ Microbiol       Date:  1987-12       Impact factor: 4.792

2.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

3.  Molecular basis for the pharmacological actions of Clostridium botulinum type C2 toxin.

Authors:  L L Simpson
Journal:  J Pharmacol Exp Ther       Date:  1984-09       Impact factor: 4.030

Review 4.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

5.  Studies on strain 84 of Clostridium botulinum.

Authors:  D F Giménez; A S Ciccarelli
Journal:  Zentralbl Bakteriol Orig       Date:  1970

6.  Infant botulism in the United States: an epidemiologic study of cases occurring outside of California.

Authors:  J G Morris; J D Snyder; R Wilson; R A Feldman
Journal:  Am J Public Health       Date:  1983-12       Impact factor: 9.308

7.  Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism.

Authors:  L M McCroskey; C L Hatheway; L Fenicia; B Pasolini; P Aureli
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

8.  Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism.

Authors:  J D Hall; L M McCroskey; B J Pincomb; C L Hatheway
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

9.  Purification and amino acid composition of type E botulinum neurotoxin.

Authors:  B R DasGupta; S Rasmussen
Journal:  Toxicon       Date:  1983       Impact factor: 3.033

10.  Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy.

Authors:  P Aureli; L Fenicia; B Pasolini; M Gianfranceschi; L M McCroskey; C L Hatheway
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

  10 in total
  11 in total

Review 1.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

2.  Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin.

Authors:  S Kozaki; J Onimaru; Y Kamata; G Sakaguchi
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

Review 3.  Update: infant botulism.

Authors:  T F Midura
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Botulinum type A neurotoxin digested with pepsin yields 132, 97, 72, 45, 42, and 18 kD fragments.

Authors:  J A Gimenez; B R DasGupta
Journal:  J Protein Chem       Date:  1993-06

5.  Characterization of a neurotoxigenic Clostridium butyricum strain isolated from the food implicated in an outbreak of food-borne type E botulism.

Authors:  X Meng; T Karasawa; K Zou; X Kuang; X Wang; C Lu; C Wang; K Yamakawa; S Nakamura
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

6.  Evaluation of a rapid air thermal cycler for detection of Mycobacterium tuberculosis.

Authors:  K Chapin; T L Lauderdale
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

7.  Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.

Authors:  Gavin Hackett; Kevin Moore; David Burgin; Fraser Hornby; Bryony Gray; Mark Elliott; Imran Mir; Matthew Beard
Journal:  Toxins (Basel)       Date:  2018-05-11       Impact factor: 4.546

8.  Characterization of the neurotoxin isolated from a Clostridium baratii strain implicated in infant botulism.

Authors:  J A Giménez; M A Giménez; B R DasGupta
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

9.  Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain.

Authors:  Y Zhou; H Sugiyama; E A Johnson
Journal:  Appl Environ Microbiol       Date:  1993-11       Impact factor: 4.792

10.  Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapins.

Authors:  E B Shelley; D O'Rourke; K Grant; E McArdle; L Capra; A Clarke; E McNamara; R Cunney; P McKeown; C F L Amar; C Cosgrove; M Fitzgerald; P Harrington; P Garvey; F Grainger; J Griffin; B J Lynch; G McGrane; J Murphy; N Ni Shuibhne; J Prosser
Journal:  Epidemiol Infect       Date:  2014-10-13       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.